Approval of esketamine for treatment-resistant depression

Lancet Psychiatry. 2020 Mar;7(3):232-235. doi: 10.1016/S2215-0366(19)30533-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Depression*
  • Depressive Disorder, Treatment-Resistant*
  • Drug Combinations
  • Humans
  • Ketamine
  • Pregnanolone
  • United States
  • United States Food and Drug Administration
  • beta-Cyclodextrins

Substances

  • Drug Combinations
  • beta-Cyclodextrins
  • brexanolone
  • Esketamine
  • Ketamine
  • Pregnanolone